AVDL. 7.80 in after-hours.. A company I've traded unsuccessfully before...but I still them follow loosely.
I've been thinking about the reason they are selling off legacy parts of the company ..profitable units...Last unit sale was July 1st for 42 MILL
A buy out is coming soon IMO . Bio is risky for sure but M@A is about to explode in Bio.
https://seekingalpha.com/news/35877...tal-sterile-injectable-drug-portfolio-for-42m
I've been following a bit of a trail from AVDL to JAZZ (ticker JAZZ) $105.00. AVDL has what JAZZ needs badly.
The existence of JAZZ almost depends on AVDL's narcolepsy drug FT218.
JAZZ isn't afraid to step in mid 3rd phase and pay up/they've done 3rd phase buyouts twice ... AVDL's FT218 is in the 3rd phase and pending approval.
Two ways to play this..I'm try to decide witch one works best..
Buy JAZZ..who's been crushed because 70% of their profits are tied to the soon to be second best narcolepsy drug on the market but minimize getting smoked on a failed trial.Less risk but I'm not interested in getting in to a long hold on JAZZ...
Or Buy AVDL and potentially double your money but open yourself up to a possible crushing with a trial failure.
Lots or rumors tying to two together out there.
Or just blow it off/I've had a couple of horrible experiences with this sort of play before and a couple of homers too.
High risk either way but "interesting"
I've been thinking about the reason they are selling off legacy parts of the company ..profitable units...Last unit sale was July 1st for 42 MILL
A buy out is coming soon IMO . Bio is risky for sure but M@A is about to explode in Bio.
https://seekingalpha.com/news/35877...tal-sterile-injectable-drug-portfolio-for-42m
I've been following a bit of a trail from AVDL to JAZZ (ticker JAZZ) $105.00. AVDL has what JAZZ needs badly.
The existence of JAZZ almost depends on AVDL's narcolepsy drug FT218.
JAZZ isn't afraid to step in mid 3rd phase and pay up/they've done 3rd phase buyouts twice ... AVDL's FT218 is in the 3rd phase and pending approval.
Two ways to play this..I'm try to decide witch one works best..
Buy JAZZ..who's been crushed because 70% of their profits are tied to the soon to be second best narcolepsy drug on the market but minimize getting smoked on a failed trial.Less risk but I'm not interested in getting in to a long hold on JAZZ...
Or Buy AVDL and potentially double your money but open yourself up to a possible crushing with a trial failure.
Lots or rumors tying to two together out there.
Or just blow it off/I've had a couple of horrible experiences with this sort of play before and a couple of homers too.
High risk either way but "interesting"